Dynavax Technologies Corp’s filing revealed that its President & COO Novack David F unloaded Company’s shares for reported $0.46 million on Dec 24 ’25. In the deal valued at $15.49 per share,30,000 shares were sold. As a result of this transaction, Novack David F now holds 111,451 shares worth roughly $1.71 million.
Then, DAVID NOVACK bought 30,000 shares, generating $464,700 in total proceeds.
Before that, Myers Scott Dunseth bought 3,800 shares. Dynavax Technologies Corp shares valued at $41,116 were divested by the Director at a price of $10.82 per share. As a result of the transaction, Myers Scott Dunseth now holds 35,004 shares, worth roughly $0.54 million.
Goldman downgraded its Dynavax Technologies Corp [DVAX] rating to a Sell from a a Neutral in a research note published on February 11, 2025; the price target was decreased to $12 from $15. A number of analysts have revised their coverage, including Goldman’s analysts, who began to cover the stock in early February with a ‘”a Neutral”‘ rating. JMP Securities began covering DVAX with “Mkt outperform” recommendation on September 27, 2022.
Price Performance Review of DVAX
On Friday, Dynavax Technologies Corp [NASDAQ:DVAX] saw its stock unchanged to $15.38. Dynavax Technologies Corp shares have risen nearly 19.88% since the year began. While a 52-week high of $15.49 was reached on 01/02/26, a 52-week low of $9.20 was recorded on 01/02/26.
Levels Of Support And Resistance For DVAX Stock
The 24-hour chart illustrates a support level at 15.37, which if violated will result in even more drops to 15.36. On the upside, there is a resistance level at 15.39. A further resistance level may holdings at 15.40.
How much short interest is there in Dynavax Technologies Corp?
A steep rise in short interest was recorded in Dynavax Technologies Corp stocks on 2025-12-15, dropping by -1.43 million shares to a total of 12.29 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 13.72 million shares. There was a decline of -11.66%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on August 06, 2021 when Goldman began covering the stock and recommended ‘”a Buy”‘ rating along with a $19 price target.
